TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin

Micaela Poetsch, Thomas Dittberner, John Kenneth Cowell, Christian Woenckhaus

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A novel candidate tumor suppressor gene, TTC4, on chromosome 1p31 has been described recently. Since aberrations in this region have been detected in malignant melanoma, we investigated DNA of paraffin-embedded sections from 16 typical naevi, 19 atypical naevi, 32 primary melanomas (15 superficial spreading melanomas, 17 nodular melanomas) and 25 metastases and DNA from four melanoma cell lines by PCR and direct sequencing analysis for mutations in all exons of TTC4. Tumors comprised a wide range of thickness (Breslow index) and Clark levels. No mutations could be detected in typical or atypical naevi, but we found seven different point mutations in the tumor samples, six of them causing an amino acid change. Ten melanoma samples belonging to nine patients showed one or more of these mutations. In detail, in six of 25 metastases, in two of 17 nodular melanomas and in two of 15 superficial spreading melanomas point mutations could be detected. In two cell lines, a loss of a whole exon could be demonstrated and in one cell line we found a point mutation. In addition, three polymorphisms were found. Our findings indicate that TTC4 may participate in the pathogenesis of malignant melanomas of the skin.

Original languageEnglish (US)
Pages (from-to)5817-5820
Number of pages4
JournalOncogene
Volume19
Issue number50
DOIs
StatePublished - Nov 23 2000
Externally publishedYes

Fingerprint

Tumor Suppressor Genes
Melanoma
Skin
Nevus
Point Mutation
Cell Line
Mutation
Exons
Neoplasm Metastasis
DNA
Paraffin
Neoplasms
Chromosomes
Amino Acids
Polymerase Chain Reaction

Keywords

  • Malignant melanoma
  • Sequencing analysis
  • TTC4

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin. / Poetsch, Micaela; Dittberner, Thomas; Cowell, John Kenneth; Woenckhaus, Christian.

In: Oncogene, Vol. 19, No. 50, 23.11.2000, p. 5817-5820.

Research output: Contribution to journalArticle

Poetsch, Micaela ; Dittberner, Thomas ; Cowell, John Kenneth ; Woenckhaus, Christian. / TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin. In: Oncogene. 2000 ; Vol. 19, No. 50. pp. 5817-5820.
@article{728e1ab39d5d40a2abdb3264dd597141,
title = "TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin",
abstract = "A novel candidate tumor suppressor gene, TTC4, on chromosome 1p31 has been described recently. Since aberrations in this region have been detected in malignant melanoma, we investigated DNA of paraffin-embedded sections from 16 typical naevi, 19 atypical naevi, 32 primary melanomas (15 superficial spreading melanomas, 17 nodular melanomas) and 25 metastases and DNA from four melanoma cell lines by PCR and direct sequencing analysis for mutations in all exons of TTC4. Tumors comprised a wide range of thickness (Breslow index) and Clark levels. No mutations could be detected in typical or atypical naevi, but we found seven different point mutations in the tumor samples, six of them causing an amino acid change. Ten melanoma samples belonging to nine patients showed one or more of these mutations. In detail, in six of 25 metastases, in two of 17 nodular melanomas and in two of 15 superficial spreading melanomas point mutations could be detected. In two cell lines, a loss of a whole exon could be demonstrated and in one cell line we found a point mutation. In addition, three polymorphisms were found. Our findings indicate that TTC4 may participate in the pathogenesis of malignant melanomas of the skin.",
keywords = "Malignant melanoma, Sequencing analysis, TTC4",
author = "Micaela Poetsch and Thomas Dittberner and Cowell, {John Kenneth} and Christian Woenckhaus",
year = "2000",
month = "11",
day = "23",
doi = "10.1038/sj.onc.1203961",
language = "English (US)",
volume = "19",
pages = "5817--5820",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "50",

}

TY - JOUR

T1 - TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin

AU - Poetsch, Micaela

AU - Dittberner, Thomas

AU - Cowell, John Kenneth

AU - Woenckhaus, Christian

PY - 2000/11/23

Y1 - 2000/11/23

N2 - A novel candidate tumor suppressor gene, TTC4, on chromosome 1p31 has been described recently. Since aberrations in this region have been detected in malignant melanoma, we investigated DNA of paraffin-embedded sections from 16 typical naevi, 19 atypical naevi, 32 primary melanomas (15 superficial spreading melanomas, 17 nodular melanomas) and 25 metastases and DNA from four melanoma cell lines by PCR and direct sequencing analysis for mutations in all exons of TTC4. Tumors comprised a wide range of thickness (Breslow index) and Clark levels. No mutations could be detected in typical or atypical naevi, but we found seven different point mutations in the tumor samples, six of them causing an amino acid change. Ten melanoma samples belonging to nine patients showed one or more of these mutations. In detail, in six of 25 metastases, in two of 17 nodular melanomas and in two of 15 superficial spreading melanomas point mutations could be detected. In two cell lines, a loss of a whole exon could be demonstrated and in one cell line we found a point mutation. In addition, three polymorphisms were found. Our findings indicate that TTC4 may participate in the pathogenesis of malignant melanomas of the skin.

AB - A novel candidate tumor suppressor gene, TTC4, on chromosome 1p31 has been described recently. Since aberrations in this region have been detected in malignant melanoma, we investigated DNA of paraffin-embedded sections from 16 typical naevi, 19 atypical naevi, 32 primary melanomas (15 superficial spreading melanomas, 17 nodular melanomas) and 25 metastases and DNA from four melanoma cell lines by PCR and direct sequencing analysis for mutations in all exons of TTC4. Tumors comprised a wide range of thickness (Breslow index) and Clark levels. No mutations could be detected in typical or atypical naevi, but we found seven different point mutations in the tumor samples, six of them causing an amino acid change. Ten melanoma samples belonging to nine patients showed one or more of these mutations. In detail, in six of 25 metastases, in two of 17 nodular melanomas and in two of 15 superficial spreading melanomas point mutations could be detected. In two cell lines, a loss of a whole exon could be demonstrated and in one cell line we found a point mutation. In addition, three polymorphisms were found. Our findings indicate that TTC4 may participate in the pathogenesis of malignant melanomas of the skin.

KW - Malignant melanoma

KW - Sequencing analysis

KW - TTC4

UR - http://www.scopus.com/inward/record.url?scp=0034706921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034706921&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1203961

DO - 10.1038/sj.onc.1203961

M3 - Article

C2 - 11126369

AN - SCOPUS:0034706921

VL - 19

SP - 5817

EP - 5820

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 50

ER -